Another drawback is the cross-sectional nature of our study, as it does not allow us to determine whether the relationship we found between high PON1 activity and hepatic manifestations was a cause or a consequence of obesity and/or NAFLD. The gene discussed is PON1; the disease is metabolic dysfunction-associated steatotic liver disease.